A 48-year-old Aboriginal man with chronic hepatitis B infection (HBeAg-negative, detectable HBV DNA) is followed in a regional clinic. He has no cirrhosis on FibroScan and normal ALT. He drinks little alcohol and has a family history of hepatocellular carcinoma (HCC). According to Australian guidance, which surveillance strategy is most appropriate for HCC?